These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

861 related articles for article (PubMed ID: 9753266)

  • 41. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: possible implication of cyclooxygenase-2 in cancer development.
    Sawaoka H; Kawano S; Tsuji S; Tsujii M; Murata H; Hori M
    J Clin Gastroenterol; 1998; 27 Suppl 1():S47-52. PubMed ID: 9872498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach.
    Maricic N; Ehrlich K; Gretzer B; Schuligoi R; Respondek M; Peskar BM
    Br J Pharmacol; 1999 Dec; 128(8):1659-66. PubMed ID: 10588920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
    Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
    Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ellagic acid facilitates indomethacin-induced gastric ulcer healing via COX-2 up-regulation.
    Chatterjee A; Chatterjee S; Das S; Saha A; Chattopadhyay S; Bandyopadhyay SK
    Acta Biochim Biophys Sin (Shanghai); 2012 Jul; 44(7):565-76. PubMed ID: 22626975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction between NSAIDs and steroid in rat stomach: safety of nimesulide as a preferential COX-2 inhibitor in the stomach.
    Kataoka H; Horie Y; Koyama R; Nakatsugi S; Furukawa M
    Dig Dis Sci; 2000 Jul; 45(7):1366-75. PubMed ID: 10961716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
    Wallace JL; Zamuner SR; McKnight W; Dicay M; Mencarelli A; del Soldato P; Fiorucci S
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G76-81. PubMed ID: 14665439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
    Muscará MN; McKnight W; Asfaha S; Wallace JL
    Br J Pharmacol; 2000 Feb; 129(4):681-6. PubMed ID: 10683192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of nitric oxide-releasing NSAID and vitamin C with classic NSAID in healing of chronic gastric ulcers; involvement of reactive oxygen species.
    Brzozowski T; Kwiecień S; Konturek PC; Konturek SJ; Mitis-Musiol M; Duda A; Bielański W; Hahn EG
    Med Sci Monit; 2001; 7(4):592-9. PubMed ID: 11433182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Meloxicam inhibits prostaglandin E(2) generation via cyclooxygenase 2 in the inflammatory site but not that via cyclooxygenase 1 in the stomach.
    Ogino K; Hatanaka K; Kawamura M; Ohno T; Harada Y
    Pharmacology; 2000 Nov; 61(4):244-50. PubMed ID: 11093076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
    Velázquez C; Praveen Rao PN; Knaus EE
    J Med Chem; 2005 Jun; 48(12):4061-7. PubMed ID: 15943479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of nitric oxide-releasing aspirin derivative on gastric functional and ulcerogenic responses in rats: comparison with plain aspirin.
    Takeuchi K; Ukawa H; Konaka A; Kitamura M; Sugawa Y
    J Pharmacol Exp Ther; 1998 Jul; 286(1):115-21. PubMed ID: 9655849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing.
    Jones MK; Wang H; Peskar BM; Levin E; Itani RM; Sarfeh IJ; Tarnawski AS
    Nat Med; 1999 Dec; 5(12):1418-23. PubMed ID: 10581086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of the cyclooxygenase-2 gene in gastric epithelium.
    Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Nakama A; Takei Y; Nagano K; Matsui H; Kawano S; Hori M
    J Clin Gastroenterol; 1997; 25 Suppl 1():S105-10. PubMed ID: 9479635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gastric effects of the selective cyclooxygenase-2 inhibitor, celecoxib, in the rat.
    Coppelli G; Guaita E; Spaggiari S; Coruzzi G
    Dig Liver Dis; 2004 Apr; 36(4):265-70. PubMed ID: 15115339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
    Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
    Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of cyclooxygenase-2 in gastric mucosal defense.
    Peskar BM; Maricic N; Gretzera B; Schuligoi R; Schmassmann A
    Life Sci; 2001 Nov; 69(25-26):2993-3003. PubMed ID: 11758826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge.
    Gretzer B; Maricic N; Respondek M; Schuligoi R; Peskar BM
    Br J Pharmacol; 2001 Apr; 132(7):1565-73. PubMed ID: 11264251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inducible cyclooxygenase may have anti-inflammatory properties.
    Gilroy DW; Colville-Nash PR; Willis D; Chivers J; Paul-Clark MJ; Willoughby DA
    Nat Med; 1999 Jun; 5(6):698-701. PubMed ID: 10371510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.